Home   Categories   Grid

Subscribe Now

Synthetic embryo with brain and beating heart created by University of Cambridge scientists

Synthetic embryo with brain and beating heart created by University of Cambridge scientists

Synthetic embryo with brain and beating heart created by University of Cambridge scientists

01 September 2022

It could aid organ repair or lead to the creation of synthetic organs for transplantation.

1

F-star Therapeutics reports $19m loss for quarter as it progresses four clinical programs

F-star Therapeutics reports $19m loss for quarter as it progresses four clinical programs

F-star Therapeutics reports $19m loss for quarter as it progresses four clinical programs

25 August 2022

The Babraham Research Campus company is due to be acquired by invoX Pharma this year.


Sosei Heptares records $20m revenues and £31m operating loss in first half of year

Sosei Heptares records $20m revenues and £31m operating loss in first half of year

Sosei Heptares records $20m revenues and £31m operating loss in first half of year

25 August 2022

CEO Chris Cargill said the biopharma is making progress on bringing much-needed medicines to patients.


Unique network map of immune system could direct scientists to new immunotherapies, say Sanger researchers

Unique network map of immune system could direct scientists to new immunotherapies, say Sanger researchers

Unique network map of immune system could direct scientists to new immunotherapies, say Sanger researchers

12 August 2022

It has required years of technological development.


Sosei Heptares strikes neurological disease drug collaboration with AbbVie worth potential $1.2bn

Sosei Heptares strikes neurological disease drug collaboration with AbbVie worth potential $1.2bn

Sosei Heptares strikes neurological disease drug collaboration with AbbVie worth potential $1.2bn

11 August 2022

The Granta Park company receives $40m upfront and up to $40m in near-term milestones.


AstraZeneca increases R&D investment after 48% rise in revenues

AstraZeneca increases R&D investment after 48% rise in revenues

AstraZeneca increases R&D investment after 48% rise in revenues

03 August 2022

Its Covid-19 medicine Evusheld is offseting declines in sales of its vaccine.


Arecor Therapeutics raising £6m to acquire diabetes medicine specialist Tetris Pharma

Arecor Therapeutics raising £6m to acquire diabetes medicine specialist Tetris Pharma

Arecor Therapeutics raising £6m to acquire diabetes medicine specialist Tetris Pharma

01 August 2022

Tetris has a licence to sell the first stable liquid ready-to-use glucagon auto-injector pen, Ogluo.


F-star Therapeutics strikes Takeda immuno-oncology deal that could be worth more than $40m

F-star Therapeutics strikes Takeda immuno-oncology deal that could be worth more than $40m

F-star Therapeutics strikes Takeda immuno-oncology deal that could be worth more than $40m

29 July 2022

The Babraham Research Campus company will receive $1m upfront.


Cancer Research UK teams up with Sosei Heptares for clinical trial of cancer immunotherapy drug candidate

Cancer Research UK teams up with Sosei Heptares for clinical trial of cancer immunotherapy drug candidate

Cancer Research UK teams up with Sosei Heptares for clinical trial of cancer immunotherapy drug candidate

28 July 2022

Patients under-served by existing immunotherapies could benefit.


Wellcome Sanger Institute launches global hub for genomic surveillance

Wellcome Sanger Institute launches global hub for genomic surveillance

Wellcome Sanger Institute launches global hub for genomic surveillance

22 July 2022

The GSU will help tackle infectious diseases, including the Covid-19 virus and malaria, using sequencing.


AstraZeneca to fund 55 more PhD studentships at University of Cambridge over five years

AstraZeneca to fund 55 more PhD studentships at University of Cambridge over five years

AstraZeneca to fund 55 more PhD studentships at University of Cambridge over five years

21 July 2022

They will have both an academic and industry supervisor.


Tailor Bio secures £650,000 grant for ovarian cancer collaboration with Illumina and University of Cambridge

Tailor Bio secures £650,000 grant for ovarian cancer collaboration with Illumina and University of Cambridge

Tailor Bio secures £650,000 grant for ovarian cancer collaboration with Illumina and University of Cambridge

21 July 2022

The Innnovate UK grant will fund development of a test showing if patients will respond to doxorubicin.


Five Cambridge scientists named among new EMBO members

Five Cambridge scientists named among new EMBO members

Five Cambridge scientists named among new EMBO members

15 July 2022

They join a group of leading life scientists.


NRG Therapeutics and Domainex to collaborate on Parkinson’s and motor neurone disease drug discovery

NRG Therapeutics and Domainex to collaborate on Parkinson’s and motor neurone disease drug discovery

NRG Therapeutics and Domainex to collaborate on Parkinson’s and motor neurone disease drug discovery

07 July 2022

It follows the award of £2.68million funding.


Altos Labs launches Cambridge Institute of Science with cellular rejuvenation mission

Altos Labs launches Cambridge Institute of Science with cellular rejuvenation mission

Altos Labs launches Cambridge Institute of Science with cellular rejuvenation mission

01 July 2022

Granta Park company arrives with mystery investors rumoured to include Jeff Bezos


Microbiotica ready to cross therapeutic threshold with clinical trials milestone

Microbiotica ready to cross therapeutic threshold with clinical trials milestone

Microbiotica ready to cross therapeutic threshold with clinical trials milestone

01 July 2022

Cambridge microbiome specialist prepares MB097 and MB310 for human testing


First patient dose as trial of Bicycle Therapeutics’ anti-tumour molecule steps up

First patient dose as trial of Bicycle Therapeutics’ anti-tumour molecule steps up

First patient dose as trial of Bicycle Therapeutics’ anti-tumour molecule steps up

17 June 2022

Company says it is pleased with early signs.


Axol Bioscience offers IPSC-derived heart cells for use in drug testing

Axol Bioscience offers IPSC-derived heart cells for use in drug testing

Axol Bioscience offers IPSC-derived heart cells for use in drug testing

16 June 2022

They can be used to test cardiotoxicity in a dish.


‘Trojan horse’ diabetes drug that could halt disease progression undergoes clinical trials at Addenbrooke’s

‘Trojan horse’ diabetes drug that could halt disease progression undergoes clinical trials at Addenbrooke’s

‘Trojan horse’ diabetes drug that could halt disease progression undergoes clinical trials at Addenbrooke’s

10 June 2022

It ‘flips the culprit immune cells into destroying themselves’, explains Prof Mark Evans.


Tripling size of Wellcome Genome Campus will benefit global science, says Prof Sir Mike Stratton

Tripling size of Wellcome Genome Campus will benefit global science, says Prof Sir Mike Stratton

Tripling size of Wellcome Genome Campus will benefit global science, says Prof Sir Mike Stratton

09 June 2022

The cancer genetics pioneer discusses the future of the campus and the importance of biodata.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More